ID
25293
Descripción
Study ID: 101468/166 Clinical Study ID: SKF-101468/166 Study Title: A Phase II, randomised, double-blind, active-controlled, dose-escalation study to determine the maximum well-tolerated starting dose of a new formulation of ropinirole in Parkinson's Disease patients not receiving other dopaminergic therapies Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 2 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: requip Study Indication: Parkinson Disease
Palabras clave
Versiones (2)
- 31/8/17 31/8/17 -
- 4/9/17 4/9/17 -
Titular de derechos de autor
GlaxoSmithKline
Subido en
31 de agosto de 2017
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Patient's Daily Diary determination of the maximum well-tolerated starting dose of ropinirole in Parkinson's Disease 101468/166
Patient's Daily Diary determination of the maximum well-tolerated starting dose of ropinirole in Parkinson's Disease 101468/166
Descripción
HEALTH RELATED EVENTS
Alias
- UMLS CUI-1
- C1562065
Descripción
event
Tipo de datos
text
Alias
- UMLS CUI [1]
- C0441471
Descripción
start date and time
Tipo de datos
datetime
Alias
- UMLS CUI [1]
- C0808070
- UMLS CUI [2]
- C1301880
Descripción
stop date and time
Tipo de datos
datetime
Alias
- UMLS CUI [1]
- C0806020
- UMLS CUI [2]
- C1522314
Descripción
Only tick the box, if the event is still going on.
Tipo de datos
text
Alias
- UMLS CUI [1]
- C0549178
Similar models
Patient's Daily Diary determination of the maximum well-tolerated starting dose of ropinirole in Parkinson's Disease 101468/166
C0376660 (UMLS CUI [1,2])
C1522634 (UMLS CUI [1,2])
C1301880 (UMLS CUI [2])
C1522314 (UMLS CUI [2])